Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Tracking local anesthetic effects using a novel perceptual reference approach.

Ettlin DA, Lukic N, Abazi J, Widmayer S, Meier ML.

J Neurophysiol. 2016 Mar;115(3):1730-4. doi: 10.1152/jn.00917.2015. Epub 2016 Jan 20.

2.

Comparison of efficacy and safety of ropivacaine with bupivacaine for intrathecal anesthesia for lower abdominal and lower limb surgeries.

Bhat SN, Himaldev, Upadya M.

Anesth Essays Res. 2013 Sep-Dec;7(3):381-5. doi: 10.4103/0259-1162.123252.

3.

The thermodynamics of general and local anesthesia.

Graesbøll K, Sasse-Middelhoff H, Heimburg T.

Biophys J. 2014 May 20;106(10):2143-56. doi: 10.1016/j.bpj.2014.04.014.

4.

Comparison of bupivacaine and lidocaine use for postoperative pain control in endodontics.

Moradi S, Naghavi N.

Iran Endod J. 2010 Winter;5(1):31-5. Epub 2010 Feb 20.

5.

Glutamate and dopamine transmission from midbrain dopamine neurons share similar release properties but are differentially affected by cocaine.

Adrover MF, Shin JH, Alvarez VA.

J Neurosci. 2014 Feb 26;34(9):3183-92. doi: 10.1523/JNEUROSCI.4958-13.2014.

6.

Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate.

Federici M, Latagliata EC, Ledonne A, Rizzo FR, Feligioni M, Sulzer D, Dunn M, Sames D, Gu H, Nisticò R, Puglisi-Allegra S, Mercuri NB.

J Biol Chem. 2014 Jan 3;289(1):264-74. doi: 10.1074/jbc.M113.495499. Epub 2013 Nov 26.

7.

Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block.

Brenneis C, Kistner K, Puopolo M, Jo S, Roberson D, Sisignano M, Segal D, Cobos EJ, Wainger BJ, Labocha S, Ferreirós N, von Hehn C, Tran J, Geisslinger G, Reeh PW, Bean BP, Woolf CJ.

Br J Pharmacol. 2014 Jan;171(2):438-51. doi: 10.1111/bph.12466.

8.

Neurological perspectives on voltage-gated sodium channels.

Eijkelkamp N, Linley JE, Baker MD, Minett MS, Cregg R, Werdehausen R, Rugiero F, Wood JN.

Brain. 2012 Sep;135(Pt 9):2585-612. doi: 10.1093/brain/aws225. Review.

9.

A review of local anesthetic cardiotoxicity and treatment with lipid emulsion.

Bourne E, Wright C, Royse C.

Local Reg Anesth. 2010;3:11-9. Epub 2010 Feb 26.

10.

Minimal structural requirements of alkyl γ-lactones capable of antagonizing the cocaine-induced motility decrease in planarians.

Baker D, Deats S, Boor P, Pruitt J, Pagán OR.

Pharmacol Biochem Behav. 2011 Nov;100(1):174-9. doi: 10.1016/j.pbb.2011.08.013. Epub 2011 Aug 22.

11.

Active immunotherapy for the Treatment of Cocaine Dependence.

Kinsey BM, Kosten TR, Orson FM.

Drugs Future. 2010 Apr 1;35(4):301-306.

12.

Anti-cocaine vaccine development.

Kinsey BM, Kosten TR, Orson FM.

Expert Rev Vaccines. 2010 Sep;9(9):1109-14. doi: 10.1586/erv.10.102. Review.

13.

[Vacuoles: a hollow threat?].

Yaksh TL.

Can J Anaesth. 2010 Mar;57(3):195-200. doi: 10.1007/s12630-009-9251-2. English, French. No abstract available.

14.

Sodium channel blockers for the treatment of neuropathic pain.

Bhattacharya A, Wickenden AD, Chaplan SR.

Neurotherapeutics. 2009 Oct;6(4):663-78. doi: 10.1016/j.nurt.2009.08.001. Review.

15.

Lipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest.

Hicks SD, Salcido DD, Logue ES, Suffoletto BP, Empey PE, Poloyac SM, Miller DR, Callaway CW, Menegazzi JJ.

Anesthesiology. 2009 Jul;111(1):138-46. doi: 10.1097/ALN.0b013e3181a4c6d7.

Supplemental Content

Support Center